 Although they're not among the largest IPOs, biotech companies are seeing a resurgence. Total capital race in the first half of this year, $21.2 billion. So things directionally seem to be going in the right place. But again, this conversation about regulation, a roiling one, has been for a few years. And as we talk about the election, what might or might not change, certainly something I think is on a lot of voters' minds.